Market Research Report
Malignant Melanoma Pricing and Reimbursement
|Published by||Datamonitor Healthcare||Product code||342059|
|Published||Content info||55 Pages
Delivery time: 1-2 business days
Prices of melanoma therapies and oncology drugs on the whole have become subject to closer scrutiny due to their high costs. Currently, the treatment of melanoma has a limited budgetary impact and Datamonitor Healthcare does not anticipate any immediate impact on the pricing of melanoma therapies. However, in the future, manufacturers may have to consider novel pricing arrangements for high-cost combination treatments.
This report addresses the following questions: